Want to see HK:1518 full AI Analyst Report?
New Century Healthcare Holding Co. Ltd. (1518) AI Stock Analysis
New Century Healthcare Holding Co. Ltd.
(HKEX:1518)
The overall score reflects a company with a fragile financial profile: recent revenue contraction, a return to losses in 2025, and ongoing capital erosion are the dominant negatives, even though leverage is moderate and the business has demonstrated strong cash generation in better years. Technicals are also weak, with the price entrenched in a downtrend and momentum indicators pointing to persistent selling pressure, which further weighs on the stock’s attractiveness. Valuation provides only a partial offset, as the combination of a negative P/E and a very high dividend yield suggests that the market prices in significant risk, leaving the stock looking more like a potential value trap than a clear opportunity.
New Century Healthcare Holding Co. Ltd. (1518) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 96.61M
- Dividend Yield
- 11.16%
- Average Volume (3M)
- 36.71K
- Price to Earnings (P/E)
- -0.6
- Beta (1Y)
- 0.26
- Revenue Growth
- -23.52%
- EPS Growth
- -226.85%
- Country
- Hong Kong
- Employees
- 1,079
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
New Century Healthcare Holding Co. Ltd. Business Overview & Revenue Model
Company Description
New Century Healthcare Holding Co. Limited functions as an investment enterprise, providing medical services specifically designed for women and children throughout the People's Republic of China. Its principal activities include specialized care in...
How the Company Makes Money
The company generates revenue primarily by delivering healthcare services through its medical facilities (e.g., hospitals/clinics) and charging patients and/or payors for clinical services. Key revenue streams typically include fees from inpatient an...
New Century Healthcare Holding Co. Ltd. Financial Statement Overview
Summary
Financial performance is below average due to a sharp revenue drop and a return to sizeable losses in 2025, with margins turning clearly negative and equity eroding over time, despite a brief period of strong profitability and cash generation in 2022–2024 and a balance sheet that is not heavily leveraged.
Income Statement
35NegativeBalance Sheet
48NeutralCash Flow
57Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 544.80M | 600.10M | 846.50M | 933.07M | 636.46M | 632.57M |
| Gross Profit | 147.48M | 175.88M | 344.96M | 407.09M | 202.14M | 198.74M |
| EBITDA | 1.87M | 30.44M | 194.43M | 234.18M | -209.54M | 41.78M |
| Net Income | -135.13M | -115.31M | 47.38M | 84.16M | -297.73M | -101.46M |
Balance Sheet | ||||||
| Total Assets | 700.76M | 745.64M | 939.13M | 944.39M | 901.38M | 1.27B |
| Cash, Cash Equivalents and Short-Term Investments | 278.97M | 283.58M | 354.52M | 304.31M | 226.08M | 223.84M |
| Total Debt | 164.05M | 166.31M | 185.83M | 206.07M | 217.02M | 280.24M |
| Total Liabilities | 448.31M | 391.51M | 430.26M | 492.63M | 540.03M | 586.66M |
| Stockholders Equity | 343.73M | 428.97M | 553.83M | 522.28M | 438.26M | 737.46M |
Cash Flow | ||||||
| Free Cash Flow | -207.32M | 8.29M | 114.10M | 148.21M | 66.16M | 9.10M |
| Operating Cash Flow | -202.41M | 17.93M | 135.92M | 158.92M | 76.28M | 22.25M |
| Investing Cash Flow | -4.56M | -62.61M | -21.03M | -8.64M | -23.07M | -15.74M |
| Financing Cash Flow | -61.02M | -79.16M | -65.18M | -73.07M | -57.26M | -79.84M |
New Century Healthcare Holding Co. Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1518, the sentiment is Negative. The current price of 0.20 is below the 20-day moving average (MA) of 0.20, below the 50-day MA of 0.22, and below the 200-day MA of 0.44, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 41.71 is Neutral, neither overbought nor oversold. The STOCH value of 133.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1518.
New Century Healthcare Holding Co. Ltd. Peers Comparison
Overall Rating
HK:141964Neutral
HK:368964Neutral
HK:386954Neutral
HK:151846Neutral
HK:072242Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 64Neutral | HKD 288.46M | 10.28 | 3.43% | 4.08% | 4.23% | 3.03% | |
| 64Neutral | HKD 581.85M | 5.27 | 6.35% | 10.92% | -0.27% | 29.73% | |
| 54Neutral | HKD 467.79M | -143.61 | -0.41% | ― | 3.16% | -101.02% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 46Neutral | HKD 96.64M | -0.60 | -34.98% | 11.16% | -23.52% | -226.85% | |
| 42Neutral | HKD 292.35M | -3.89 | -10.76% | 8.80% | -1.37% | -334.69% | |
| 41Neutral | HKD 1.10B | 73.81 | 0.48% | 1.16% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1518 | New Century Healthcare Holding Co. Ltd. | 0.20 | -0.61 | -75.56% | |
| HK:1419 | Human Health Holdings Ltd. | 0.73 | -0.06 | -6.96% | |
| HK:3689 | Guangdong Kanghua Healthcare Co., Ltd. Class H | 1.74 | 0.04 | 2.17% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.28 | -2.71 | -45.24% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.15 | -0.12 | -43.01% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.38 | -0.07 | -15.35% |
New Century Healthcare Holding Co. Ltd. Corporate Events
New Century Healthcare Swings to Deeper Interim Loss on Falling Patient Volumes and Regulatory Provision
New Century Healthcare reported interim revenue of RMB249.0 million for the six months ended June 30, 2026, down from RMB304.5 million a year earlier, as both outpatient and inpatient medical service income declined. Outpatient revenue fell 16.5% to...
New Century Healthcare flags wider interim loss on provision for frozen bank accounts
New Century Healthcare Holding Co. Ltd. warned that it expects to post a loss attributable to owners of about RMB85 million for the six months ended June 30, 2026, widening from a loss of roughly RMB65.2 million a year earlier. The interim figures ar...
New Century Healthcare Sets Board Meeting to Approve Interim Results
New Century Healthcare Holding Co. Ltd. has scheduled a board meeting for August 31, 2026 to review and approve its interim results for the six months ended June 30, 2026. The session will also address other business matters, signaling routine govern...
New Century Healthcare Flags Bank Account Freeze Linked to Partner Probe
New Century Healthcare disclosed that in late April 2026 some, but not all, of its bank accounts were frozen in connection with an investigation by the Beijing Mentougou Supervisory Committee involving one of its cooperative partners. About RMB218 mi...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 25, 2026